(Q44805804)

English

Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory

scientific article published on 4 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

marginal zone B-cell

1 reference

based on heuristic

inferred from title

immunological memory

1 reference

based on heuristic

inferred from title

3

object named as

Wim Jiskoot

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Melody Sauerborn

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Miranda M C van Beers

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Grzegorz M Kijanka

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Louis Boon

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Huub Schellekens

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vera Brinks

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

4 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

255-263

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

https://scigraph.springernature.com/pub.10.1007/s10875-012-9783-z

0 references

How to predict and prevent the immunogenicity of therapeutic proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

The implications of immunogenicity for protein-based multiple sclerosis therapies

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Epoetin-associated pure red cell aplasia: past, present, and future considerations

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Antibodies against interferon-beta in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Molecular pathways regulating CD4+ T cell differentiation, anergy and memory with implications for vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Development of a transgenic mouse model immune tolerant for human interferon Beta.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

B cell development pathways

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

The cellular basis of T-cell memory

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

T and B memory cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Tolerance induction of IgG+ memory B cells by T cell-independent type II antigens

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

B-lymphocyte responses to trinitrophenyl-conjugated Ficoll: requirement for T lymphocytes and Ia-bearing adherent cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

T cell regulation of IgG subclass antibody production in response to T-independent antigens

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Unresponsiveness following immunization with the T-cell-independent antigen dextran B512. Can it be abrogated?

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9783-Z

21 January 2018

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell control of the antibody response to the T-independent antigen, DAGG-Ficoll

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory".

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of biotherapeutics-an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological mechanism underlying the immune response to recombinant human protein therapeutics

1 reference

https://pubmed.ncbi.nlm.nih.gov/22945588

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-012-9783-Z

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44805804&oldid=2043470705"